Center for Substance Abuse Prevention Drug Testing Advisory Board; Notice of Availability of Report of Fiscal Year 2023 Closed or Partially Closed Meetings, 85226 [2024-24834]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
85226
Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices
Health, 6701 Rockledge Drive, Room 1011–H,
Bethesda, MD 20894, (301) 402–4341,
thomascp@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Study In
Cancer Biology Area Review.
Date: November 15, 2024.
Time: 11 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Charles Morrow, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–408–
9850, morrowcs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Respiratory, Cardiac and Circulatory
Sciences.
Date: November 15, 2024.
Time: 1 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kirk E. Dineley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 806E,
Bethesda, MD 20892, (301) 867–5309,
dineleyke@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Biotherapeutics
Development (CBD).
Date: November 18–19, 2024.
Time: 9 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Laurie Ann Shuman Moss,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, laurie.shumanmoss@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Data Management and Analysis/Clinical
Informatics and Digital Health Special
Emphasis Panel.
Date: November 18–19, 2024.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Amy Kathleen Wernimont,
BS, Ph.D., Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
Bethesda, MD 20892, 301–827–6427,
amy.wernimont@nih.gov.
VerDate Sep<11>2014
17:40 Oct 24, 2024
Jkt 265001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Metabolic, Cerebrovascular, Environmental,
and Sleep Factors in Alzheimer’s Disease and
Related Dementias (ADRD).
Date: November 18–19, 2024.
Time: 9 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jennifer Kielczewski,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, jennifer.kielczewski@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Drug Development and
Therapeutics (CDDT).
Date: November 18–19, 2024.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–22–
180: Maximizing Investigators’ Research
Award.
Date: November 18, 2024.
Time: 9:30 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mollie Kim Manier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0510, mollie.manier@
nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
HIV/AIDS Intra- and Inter-personal
Determinants and Behavioral Interventions
Study Section.
Date: November 18–19, 2024.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mark P. Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
PO 00000
Frm 00091
Fmt 4703
Sfmt 9990
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 21, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–24878 Filed 10–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention Drug Testing Advisory
Board; Notice of Availability of Report
of Fiscal Year 2023 Closed or Partially
Closed Meetings
Substance Abuse and Mental
Health Services Administration, HHS.
AGENCY:
ACTION:
Notice.
A report summarizing the
closed or partially closed meeting
activities of the SAMHSA’s Center for
Substance Abuse Prevention Drug
Testing Advisory Board during fiscal
year 2023 has been prepared. A copy of
this report has been filed with the
Library of Congress.
SUMMARY:
Applicable Date: This notice is
applicable October 21, 2024.
DATES:
The report is available by
contacting the DTAB designated federal
official, Lisa Davis.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Lisa
Davis, Lisa.Davis@samhsa.hhs.gov.
Phone: (240) 276–1440.
There is a
Departmental requirement to complete
and submit an Annual Report on
Federal advisory committees when an
entire or portion of the meeting is closed
to the public as required by Section
10(d) of the Federal Advisory
Committee Act (FACA).
Copies of these reports for FY 2023
are being submitted to the Library of
Congress, FACA Desk for public
inspection and use.
SUPPLEMENTARY INFORMATION:
Dated: October 21, 2024.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2024–24834 Filed 10–24–24; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Page 85226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24834]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention Drug Testing Advisory
Board; Notice of Availability of Report of Fiscal Year 2023 Closed or
Partially Closed Meetings
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: A report summarizing the closed or partially closed meeting
activities of the SAMHSA's Center for Substance Abuse Prevention Drug
Testing Advisory Board during fiscal year 2023 has been prepared. A
copy of this report has been filed with the Library of Congress.
DATES: Applicable Date: This notice is applicable October 21, 2024.
ADDRESSES: The report is available by contacting the DTAB designated
federal official, Lisa Davis.
FOR FURTHER INFORMATION CONTACT: Lisa Davis, [email protected].
Phone: (240) 276-1440.
SUPPLEMENTARY INFORMATION: There is a Departmental requirement to
complete and submit an Annual Report on Federal advisory committees
when an entire or portion of the meeting is closed to the public as
required by Section 10(d) of the Federal Advisory Committee Act (FACA).
Copies of these reports for FY 2023 are being submitted to the
Library of Congress, FACA Desk for public inspection and use.
Dated: October 21, 2024.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2024-24834 Filed 10-24-24; 8:45 am]
BILLING CODE 4162-20-P
